Výsledky vyhledávání

Akademický článek

US Budget Impact Model for Selinexor, Bortezomib, and Dexamethasone for the Treatment of Previously Treated Multiple Myeloma

Autor: Dolph M, Tremblay G, Leong H

Publikováno v: ClinicoEconomics and Outcomes Research, Vol Volume 13, Pp 493-502 (2021)

Mike Dolph, 1 Gabriel Tremblay, 1 Hoyee Leong 2 1Health Economics Department, Purple Squirrel Economics, New York, NY, 10010, USA; 2Health Economics and Outcomes Research, Global Medical and Scientific Affairs, Karyopharm Therapeutics, Newton, MA, 02

Externí odkaz: https://doaj.org/article/b290933190d74946879c25d35717c86c

Zobrazit plný text záznamu

Akademický článek

Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia

Autor: Tremblay G, Dolph M, Bhor M, Said Q, Elliott B, Briggs A

Publikováno v: ClinicoEconomics and Outcomes Research, Vol Volume 10, Pp 705-713 (2018)

Gabriel Tremblay,1 Mike Dolph,1 Menaka Bhor,2 Qayyim Said,2 Brian Elliott,2 Andrew Briggs3 1Department of Health Economics, Purple Squirrel Economics, New York, NY, USA; 2Department of Health Economics and Outcomes Research, Novartis Pharmaceuticals,

Externí odkaz: https://doaj.org/article/4c55fe6980bc47c4ba5c90c5b82631e3

Zobrazit plný text záznamu

Akademický článek

Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia

Autor: Tremblay G, Dolph M, Bhor M, Said Q, Roy A, Elliott B, Briggs A

Publikováno v: ClinicoEconomics and Outcomes Research, Vol Volume 10, Pp 715-721 (2018)

Gabriel Tremblay,1 Mike Dolph,1 Menaka Bhor,2 Qayyim Said,2 Anuja Roy,2 Brian Elliott,3 Andrew Briggs4 1Health Economics, Purple Squirrel Economics, New York, NY, USA; 2Health Economics and Outcomes Research, Novartis Pharmaceuticals, East Hanover, N

Externí odkaz: https://doaj.org/article/ec0313e12cc546a79c0edc00ad68e5d8

Zobrazit plný text záznamu

Akademický článek

Matching-adjusted indirect treatment comparison of ribociclib and palbociclib in HR+, HER2− advanced breast cancer

Autor: Tremblay G, Chandiwana D, Dolph M, Hearnden J, Forsythe A, Monaco M

Publikováno v: Cancer Management and Research, Vol Volume 10, Pp 1319-1327 (2018)

Gabriel Tremblay,1 David Chandiwana,2 Mike Dolph,1 Jaclyn Hearnden,1 Anna Forsythe,1 Mauricio Monaco2 1Purple Squirrel Economics, New York, NY, USA; 2Novartis Pharmaceutical Corporation, East Hanover, NJ, USA Background: Ribociclib (RIBO) and palboci

Externí odkaz: https://doaj.org/article/594ca4140aeb41c4b84097e67e20e993

Zobrazit plný text záznamu

Akademický článek

Systematic review of health state utility values for acute myeloid leukemia

Autor: Forsythe A, Brandt PS, Dolph M, Patel S, Rabe APJ, Tremblay G

Publikováno v: ClinicoEconomics and Outcomes Research, Vol Volume 10, Pp 83-92 (2018)

Anna Forsythe,1 Patricia S Brandt,2 Mike Dolph,1 Sachin Patel,3 Adrian Paul J Rabe,1 Gabriel Tremblay1 1Purple Squirrel Economics, New York, NY, 2Novartis Pharmaceuticals, East Hanover, NJ, USA; 3Novartis Pharmaceuticals UK Limited, Frimley, Camberle

Externí odkaz: https://doaj.org/article/c68cffbd1bfc4bb8ad1c809b9b3a744f

Zobrazit plný text záznamu